Vivus Inc Drug Patent Portfolio
Vivus Inc owns 1 orange book drug protected by 5 US patents Given below is the list of Vivus Inc's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US8221747 | Stable pancreatic enzyme compositions | 20 Feb, 2028 | Active |
US8562978 | Stable digestive enzyme compositions | 20 Feb, 2028 | Active |
US8562979 | Stable digestive enzyme compositions | 20 Feb, 2028 | Active |
US8562980 | Stable digestive enzyme compositions | 20 Feb, 2028 | Active |
US8562981 | Stable digestive enzyme compositions | 20 Feb, 2028 | Active |
Latest Legal Activities on Vivus Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Vivus Inc.
Activity | Date | Patent Number |
---|---|---|
Payment of Maintenance Fee, 12th Year, Large Entity | 03 Jan, 2024 | US8221747 |
Payment of Maintenance Fee, 8th Year, Large Entity | 07 Apr, 2021 | US8562978 |
Payment of Maintenance Fee, 8th Year, Large Entity | 07 Apr, 2021 | US8562981 |
Payment of Maintenance Fee, 8th Year, Large Entity | 07 Apr, 2021 | US8562979 |
Payment of Maintenance Fee, 8th Year, Large Entity | 07 Apr, 2021 | US8562980 |
Payment of Maintenance Fee, 8th Year, Large Entity | 17 Jan, 2020 | US8221747 |
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Sep, 2014 | US8221747 |
Email Notification
Critical
| 29 Sep, 2014 | US8562978 |
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Sep, 2014 | US8562981 |
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Sep, 2014 | US8562979 |
Email Notification
Critical
| 29 Sep, 2014 | US8562980 |
Email Notification
Critical
| 29 Sep, 2014 | US8221747 |
Email Notification
Critical
| 29 Sep, 2014 | US8562979 |
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Sep, 2014 | US8562978 |
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Sep, 2014 | US8562980 |
Vivus Inc's Family Patents
Vivus Inc Drug List
Given below is the complete list of Vivus Inc's drugs and the patents protecting them.
1. Pancreaze
Pancreaze is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US8221747 | Stable pancreatic enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
US8562978 | Stable digestive enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
US8562979 | Stable digestive enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
US8562980 | Stable digestive enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
US8562981 | Stable digestive enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Pancreaze's drug page